|
|
Changes and clinical significance of serum high mobility group protein B1 and inflammatory cytokines in patients with acute exacerbation of chronic obstructive pulmonary disease |
FENG Yu-jia1 PI Xiu-jie2 GAO Wei-wei2 FU Chang-you2 XU Zhi-jing |
1. Qiqihar Medical University Logistics Management Office, Heilongjiang Province, Qiqihar 161006, China;
2. Department of Respiratory Medicine, The First Affiliated Hospital of Qiqihar Medical University, Heilongjiang Province, Qiqihar 161041, China;
3. Department of Geriatrics, The Third affiliated Hospital of Qiqihar Medical University, Heilongjiang Province, Qiqihar 161041, China |
|
|
Abstract Objective To investigate the changes and clinical significance of serum high mobility group protein B1 and inflammatory cytokines in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods A total of 200 COPD patients admitted to The First Affiliated Hospital of Qiqihar Medical University from February 2018 to February 2020 were selected as the research objects, and were divided into COPD stable stage group (90 cases)and COPD acute exacerbation group (110 cases) according to their disease characteristics. At the same time, 100 healthy subjects were selected as the control group. The forced expiratory volume in the first second/forced vital capacity (FEV1/FVC), the percentage of FEV1 in the predicted value (FEV1%), the serum levels of high mobility group protein B1 (HMGB1), C-reactive protein (CRP), interleukin-6 (IL-6) and interleukin-18 (IL-18) in three groups were observed. The correlation between FEV1/FVC, FEV1% and HMGB1, CRP, IL-6 and IL-18 in patients with acute exacerbation of COPD was analyzed. Results The FEV1/FVC and FEV1% in COPD acute exacerbation group were lower than those in the control group and COPD stable stage group, and the HMGB1, CRP, IL-6 and IL-18 were higher than those in the control group and COPD stable stage group, FEV1/FVC and FEV1% in COPD stable stage group were lower than those in control group, and HMGB1, CRP, IL-6 and IL-18 were higher than those in control group, the differences were statistically significant (P<0.05). In patients with acute exacerbation of COPD, FEV1/FVC and FEV1% were negatively correlated with HMGB1 and CRP, while positively correlated with IL-6 and IL-18 (P<0.05). Conclusion The levels of HMGB1, CRP, IL-6 and IL-18 are abnormally changed in COPD patients, which are related to the lung function of the patients.
|
|
|
|
|
Cite this article: |
FENG Yu-jia,PI Xiu-jie,GAO Wei-wei, et al. Changes and clinical significance of serum high mobility group protein B1 and inflammatory cytokines in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. 中国当代医药, 2021, 28(21): 59-61转65.
|
|
|
|
URL: |
http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I21/59 |
[1] |
刘艳妮,姚艳粉.猪肺磷脂注射液联合经鼻间歇正压通气治疗新生儿呼吸窘迫综合征的临床疗效及其对血清人高迁移率族蛋白B1、重组人巨噬细胞移动抑制因子水平的影响[J].实用心脑肺血管病杂志,2019,27(6):94-97.
|
[2] |
刘涛,刘伟欣,贺明,等.丹参酮Ⅱ-A 磺酸钠通过调控高迁移率组蛋白1 减轻内毒素导致的大鼠急性肺损伤[J].实用医学杂志,2020,36(2):164-169.
|
[3] |
陈载鑫,莫绮雯,梁洁如,等.血清S100A8/A9 和高迁移率族蛋白B1 水平与心肺复苏后缺血再灌注脑损伤程度及预后判断的关系[J].中国民间疗法,2019,27(24):63-65.
|
[4] |
朱美爱,白植地,吴振兴,等.慢性阻塞性肺疾病急性加重期患者血清高迁移率族蛋白B1、C-反应蛋白、 白细胞介素-6 和白细胞介素-18 变化与临床意义[J].中国卫生检验杂志,2020,30(20):2482-2484.
|
[5] |
凌杰兵,傅一牧,马斌.慢性阻塞性肺疾病急性加重期患者血清高迁移率蛋白1、 表面活性蛋白D、 肿瘤坏死因子-α 的表达及意义[J].中国临床医生杂志,2018,46(3):264-267.
|
[6] |
张纪勋,许艳丽.肺泡灌洗对肺脓肿患者肺表面活性蛋白A 与高迁移率蛋白1 水平的影响分析[J].山西医药杂志,2019,48(7):812-814.
|
[7] |
吴海兰,戴伟,赵明,等.高迁移率族蛋白B1 在急性肺损伤中的研究进展[J].临床肺科杂志,2019,24(12):2276-2280.
|
[8] |
杨俊,胡克,杜春玲,等.基于高迁移率族蛋白B1 信号通路分析乌司他丁对早期放射性肺损伤的保护机制[J].中国医院用药评价与分析,2020,20(2):171-175.
|
[9] |
游泳,刘升明.高迁移率族蛋白B1 在慢性阻塞性肺疾病发病中的作用[J].实用医学杂志,2018,34(21):3499-3502.
|
[10] |
Yao Y,Zheng Z,Song Q.Mesenchymal stem cells:A double-edged sword in radiation-induced lung injury:MSCs and radiation-induced lung injury[J].Thorac Cancer,2018,9(2):208-217.
|
[11] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264.
|
[13] |
Niu S,Ma X,Zhang Y,et al.MicroRNA-19a and microRNA19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB[J].PLoS One,2018,13(2):e0192790.
|
[14] |
Wong S L,To J,Santos J,et al.Proteomic analysis of extracellular HMGB1 identifies binding partners and exposes its potential role in airway epithelial cell homeostasis[J].J Proteome Res,2018,17(1):33-45.
|
[15] |
Liu R,Shen L,Qu N,et al.MiR-19a promotes migration and invasion by targeting RHOB in osteosarcoma[J].Onco Targets Ther,2019,23(12):7801-7808.
|
[16] |
Rebetz J,Semple J W,Kapur R.The pathogenic involvement of neutrophils in acute respiratory distress syndrome and transfusion-related acute lung injury[J].Transfus Med Hemother,2018,45(5):290-298.
|
[17] |
Zhang D,Zhou J,Ye LC,et al.Autophagy maintains the integrity of endothelial barrier in LPS-induced lung injury[J].J Cell Physiol,2018,233(1):688-698.
|
[18] |
Luan Z,Hu B,Wu L,et al.Unfractionated heparin alleviates human lung endothelial barrier dysfunction induced by High Mobility Group Box 1 through regulation of P38-GSK3b-snail signaling pathway[J].Cell Physiol Biochem,2018,46(5):1907-1918.
|
[19] |
Wang SW,Chen YR,Chow JM,et al.Stimulation of Fas/FasL-mediated apoptosis by luteolin through enhancement of histone H3 acetylation and c-Jun activation in HL-60 leukemiacells[J].Mol Carcinog,2018,57(7):866877.
|
[20] |
Liu B,Zhang Y,Fan Y,et al.Leucine rich repeat neuronal protein-1suppresses apoptosis of gastric cancer cells through regulation of Fas/FasL[J].Cancer Sci,2019,110(7):2145-2155.
|
[12] |
王方平,张平安,杨晓燕.高迁移率蛋白B1 介导Toll 样受体信号通路的研究进展[J].现代检验医学杂志,2017,32(3):162-164.
|
|
|
|